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Abstract
Background: Several equations have been developed to estimate glomerular filtration rate (eGFR). The common
equations used were derived from populations predominantly comprised of Caucasians with chronic kidney disease
(CKD). Some of the equations provide a correction factor for African-Americans due to their relatively increased
muscle mass and this has been extrapolated to black Africans. Studies carried out in Africa in patients with CKD
suggest that using this correction factor for the black African race may not be appropriate. However, these studies
were not carried out in healthy individuals and as such the extrapolation of the findings to an asymptomatic black
African population is questionable. We sought to compare the proportion of asymptomatic black Africans reported
as having reduced eGFR using various eGFR equations. We further compared the association between known risk
factors for CKD with eGFR determined using the different equations.
Methods: We used participant and laboratory data collected as part of a global reference interval study conducted
by the Committee of Reference Intervals and Decision Limits (C-RIDL) under the International Federation of Clinical
Chemistry (IFCC). Serum creatinine values were used to calculate eGFR using the Cockcroft-Gault (CG), re-expressed
4 variable modified diet in renal disease (4v–MDRD), full age spectrum (FAS) and chronic kidney disease epidemiology
collaboration equations (CKD-EPI). CKD classification based on eGFR was determined for every participant.
Results: A total of 533 participants were included comprising 273 (51.2%) females. The 4v–MDRD equation without
correction for race classified the least number of participants (61.7%) as having an eGFR equivalent to CKD stage G1
compared to 93.6% for CKD-EPI with correction for race. Only age had a statistically significant linear association with
eGFR across all equations after performing multiple regression analysis. The multiple correlation coefficients for CKD risk
factors were higher for CKD-EPI determined eGFRs.
Conclusions: This study found that eGFR determined using CKD-EPI equations better correlated with a prediction
model that included risk factors for CKD and classified fewer asymptomatic black Africans as having a reduced eGFR
compared to 4v–MDRD, FAS and CG corrected for body surface area.
Keywords: MDRD, CKD-EPI, Cockcroft-Gault, FAS, eGFR
* Correspondence: g_omuse@yahoo.com
1Department of Pathology, Aga Khan University Hospital Nairobi, P.O. Box
30270-00100, Nairobi, Kenya
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Omuse et al. BMC Nephrology  (2017) 18:369 
DOI 10.1186/s12882-017-0788-y
Background
Routine reporting of estimated glomerular filtration rate
(eGFR) by medical laboratories for every serum creatinine
request has been encouraged as a way of screening for
chronic kidney disease (CKD) and has been shown to
increase the absolute number of appropriate referrals to
nephrologists [1]. Patients with early CKD may be asymp-
tomatic and therefore reporting eGFR may help in early
detection and appropriate interventions to stop or reverse
progression of the disease [2].
The use of eGFR equations instead of creatinine clear-
ance (CrCl) is preferred due to the difficulties associated
with accurately collecting a 24 h urine sample. The most
popular equations for estimating GFR are Cockcroft-Gault
(CG), 4 variable modified diet in renal disease (4v–MDRD)
and chronic kidney disease epidemiology collaboration
(CKD-EPI). The CG equation was derived from an
inpatient population comprising predominantly male
patients with CKD [3]. The equation doesn’t correct for
race and one requires the patient’s height and weight to
correct for body surface area (BSA) in order to accurately
classify CKD. The 4v–MDRD equation was derived from a
population with kidney disease comprising a predomin-
antly white population. Despite the low percentage of
African-Americans in this study, they determined a
correction for race [4]. It has been assumed, given the an-
cestral linkage between African Americans and black Afri-
cans that this correction should apply to black Africans.
However, a study carried out in South Africa that mea-
sured GFR in black South Africans with established CKD
or risk factors for developing CKD concluded that eGFR
based on the 4v–MDRD equation without correction for
race better correlated with measured GFR (mGFR) and
had less bias [5]. A similar study carried out in Ghana in a
rural African population arrived at a similar conclusion,
however, this study compared eGFR to creatinine clearance
[6]. Both CG and 4v–MDRD have been shown to under-
estimate normal and high mGFR values with a greater
negative bias seen with CG [7, 8]. One of the drawbacks of
the 4v–MDRD equation is that it doesn’t accurately classify
patients with early CKD, in particular those with values
>60 ml/min/1.73m2. This is not surprising given that it
was derived from patients with CKD who had a mean
eGFR of 39.8 ml/min/1.73m2. The utility of this equation
in screening for CKD in an asymptomatic patient with no
known risk factors for CKD is questionable given that sub-
jectively healthy individuals generally have an eGFR in the
range where the 4v–MDRD equation is inaccurate. The
CKD-EPI equation has been found to better correlate with
mGFR especially in those with eGFR > 60 ml/min/1.73m2
[9]. In a study carried out in Kenya amongst HIV patients
with a median mGFR of 115 ml/min/1.73m2, both
CKD-EPI and 4v–MDRD performed better without
correction for race with CKD-EPI estimates being more
precise [10]. A new equation called the full age spectrum
(FAS) equation has been developed by Pottel et al. which
factors in correction for race, age and gender by including
population specific mean or median serum creatinine
values in the determination of eGFR. This equation has the
advantage of being applicable across different age groups
from children as young as 2 years to the elderly above
65 years of age. The equation is yet to be validated in a
black African population and was derived from population
datasets largely comprising Caucasians [11]. Most of the
studies done in Africa that have concluded that correcting
for race is not necessary for a black African population
were carried out in populations comprising patients with
CKD or at a high risk of developing CKD. The extrapola-
tion of this finding to an asymptomatic population should
not be done without evidence that this observation is
consistent.
None of the eGFR equations that are routinely used
were derived from a black African population and as
such their appropriateness in assessing kidney function
in this population needs to be evaluated. Since creatinine
generation is determined primarily by muscle mass and
dietary intake [12], it is reasonable to assume that the
performance of eGFR equations will be influenced by
the extent to which the body habitus of an African
population differs from the reference populations used
when deriving them. Given the paucity of data on the per-
formance of these equations in a subjectively healthy popu-
lation, we compared eGFR determined using various eGFR
equations and assessed which eGFR values best correlated
with known risk factors for CKD and the proportion of
asymptomatic black Africans with no known risk factors
for CKD classified as having a reduced or normal eGFR by
each equation.
Methods
We determined eGFR using single measurements of
serum creatinine from Kenyans participating in a cross-
sectional multicenter, multinational, global reference
interval study which is part of an initiative by the Commit-
tee of Reference Intervals and Decision Limits (C-RIDL)
under the auspices of the International Federation of
Clinical Chemistry (IFCC). The aim of the study is to
determine reference intervals for common laboratory tests
across different geographical regions and populations, and
to explore determinants of variation in reference intervals.
Kenya is one of the three participating countries in Africa,
the other ones being Nigeria and South Africa. For the
Kenyan study, we recruited subjectively healthy black
African adults who met the inclusion criteria as spelt out
in the published protocol [13]. Participants were recruited
from Nairobi which is the capital city, Kiambu county
which is in central Kenya, Kisii which is in the western
part of Kenya, and Nakuru county which is in the Great
Omuse et al. BMC Nephrology  (2017) 18:369 Page 2 of 8
Rift valley. Recruitment was carried out between January
and October 2015. All participants had undergone an
overnight fast and written informed consent was sought
from each participant after giving a written and verbal ex-
planation of the study. Recruitment was stratified into 4
age groups: 18–29, 30–39, 40–49 and 50–65 years with al-
most similar numbers of males and females in each age
strata. The recruitment procedure, sample handling and
analysis has previously been described [14]. Briefly, all par-
ticipants had measurements of blood pressure (BP), ab-
dominal circumference and body mass index (BMI) done,
samples were collected and centrifuged within 4 h after
collection and stored at -80oc until shipment on dry ice to
the Pathcare reference laboratory in South Africa. As part
of the reference interval study, all participating laborator-
ies used a common mini-panel of sera with assigned
values to ensure accuracy of reported results and align-
ment of values if any biases were identified. Urine samples
to test for haematuria and proteinuria were not collected.
Serum creatinine was determined using a standardized
kinetic colour test (Jaffé method) and fasting plasma glu-
cose (FPG) by an enzymatic UV test (hexokinase method)
both measured on a Beckman AU5800 (Schizuoka, Japan).
Calculation of body surface area (BSA) was done using the
DuBois method [15]: BSA (m2) = [71.84 ×weight (kg)0.425 ×
height (cm)0.725]/10 000..
Calculation of eGFR (mL/min/1.73 m2) was done
using the following equations:
Re-expressed 4-v MDRD [16]
175 S‐Cr μmol=Lð Þ=88:4½ ‐1:154  age yearsð Þ‐0:203
 0:742 if femaleð Þ  1:212 if African Americanð Þ
Cockcroft-Gault normalized to 1.73m2 [3]
140 age in yearsð Þ  weight kgð Þ  0:85 if femaleð Þ  1:73 m2ð Þ½ =
S‐Cr μmol=Lð Þ  0:814 BSA m2  
CKD-EPI for blacks [9]
Female with Creatinine≤62 μmol=L; 166
 Scr=61:9ð Þ‐0:329  0:993ð ÞAge
Female with Creatinine > 62 μmol=L; 166
 Scr=61:9ð Þ‐1:209  0:993ð ÞAge
Male with Creatinine≤80 μmol=L; 163
 Scr=79:6ð Þ‐0:411  0:993ð ÞAge
Male with Creatinine > 80 μmol=L; 163
 Scr=79:6ð Þ‐1:209  0:993ð ÞAge
CKD-EPI for other races [9]
Female with Creatinine≤62 μmol=L; 144
 Scr=61:9ð Þ‐0:329  0:993ð ÞAge
Female with Creatinine > 62 μmol=L; 144
 Scr=61:9ð Þ‐1:209  0:993ð ÞAge
Male with Creatinine≤80 μmol=L; 141
 Scr=79:6ð Þ‐0:411  0:993ð ÞAge
Male with Creatinine > 80 μmol=L; 141
 Scr=79:6ð Þ‐1:209  0:993ð ÞAge
FAS equation [11].
2–40 years; 107.3/(Scr/Q).
> 40 years; (107.3/[Scr/Q])0.988Age ‐ 40.
Where Scr is serum creatinine, Q is the mean or median
population specific serum creatinine, Age is in years.
Classification of CKD based on eGFR was done using
the 2012 Kidney Disease: Improving Global Outcomes
(KDIGO) clinical practice guidelines as follows [17]:
GFR category GFR (ml/min/1.73m2) Terms
G1 ≥ 90 Normal or high
G2 60–89 Mildly decreased
G3a 45–59 Mildly to moderately decreased
G3b 30–44 Moderately to severely decreased
G4 15–29 Severely decreased
G5 < 15 Kidney failure
A cut off-of 75 ml/min/1.73m2 was also used to define
reduced eGFR for participants less than 40 years of age
as proposed by Pottel et al. [18]. Sample size calculation
for the primary study was based on recommendations
from the Clinical Laboratory Standards Institute (CLSI)
which requires a minimum of 120 study participants per
stratification in order to get 90% confidence limits
around the upper and lower limits of a reference interval
[19]. Since we had 4 age stratifications, a minimum
sample size of 480 was required to achieve the primary
objective for the reference interval study.
Statistical analysis
Descriptive and inferential statistics were performed
using SPSS version 20 (IBM corp, Armonk, New York,
USA). Medians and interquartile ranges (IQR) were
calculated for continuous variables before and after
stratification based on gender. Comparison of medians
or mean ranks between males and females was done
using the Mann-Whitney U test. Classification of eGFR
was reported as proportions. Multiple regression analysis
(MRA) was also performed to determine the extent to
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which the CKD risk factors independently added to the
eGFR regression model. Calculation of eGFR, BSA and
classification of CKD was done using Microsoft excel
2010 (Redmond, USA). A p-value less than 0.05 was
considered statistically significant.
Results
A total of 533 participants were included comprising
260 (48.8%) males and 273 (51.2%) females. The median
age, BMI and FPG between males and females wasn’t
statistically different neither was eGFR except when
determined using CG corrected for BSA. Males had
higher serum creatinine values. Five participants didn’t
have FPG assayed due to insufficient samples. A
summary of the participants’ demographic and clinical
descriptive statistics are shown in Table 1.
Overall, women had higher eGFR compared to men.
Of the 6 equations, the 4v–MDRD equation without
correction for race had the lowest median eGFR and
classified the least number of participants (61.7%) as
having an eGFR ≥90 mL/min/1.73m2 compared to 93.6%
by CKD-EPI with correction for race as shown in Table 2.
The 4v–MDRD equation without correction for race
classified the highest percentage of participants (0.9%) as
having an eGFR <60 ml/min/1.73m2. The number of
individuals with an eGFR < 60 ml/min/1.73m2 was less
than 1% regardless of the equation used. Using a cut off
of 75 ml/min/1.73m2, the 4v–MDRD equation without
correction for race also classified the highest proportion
of participants under the age of 40 years (7.8%) as having
reduced eGFR as shown in Table 2.
After multiple regression analysis, only age had an
unstandardized coefficient (B) that was statistically
significantly different from zero across all the 6
equations. Overall, the correlation between eGFR and
risk factors for CKD varied depending on which
equation was used. The 6 CKD risk factors evaluated
had a stronger association with the CKD-EPI deter-
mined eGFRs as evidenced by higher multiple correl-
ation coefficients as shown in Table 2.
Discussion
The prevalence of eGFR < 60 ml/mim/1.73 m2 was less
than 1% according to the 6 equations evaluated in this
study which is reflective of the deliberate recruitment of
healthy individuals for the reference interval study. In a
randomly selected rural and urban adult population in
Cameroon, Kaze et al. found that 10.9% had a CKD-EPI
determined eGFR < 60 ml/min/1.73m2 with this being
more common in the urban population [20]. Both the
CKD-EPI and 4v–MDRD equations with correction for
race did not classify any participant as having a reduced
eGFR in our study largely comprised of an urban popu-
lation. Assuming that a healthy population should pre-
dominantly have an eGFR > 90 ml/min/1.73m2, the
CKD-EPI equation with correction for race classified
more participants into stage G1 suggesting that it could
be a more ideal equation when estimating eGFR in an
Table 1 Descriptive characteristics of participants
Male (n = 260) Female (n = 273) Total (n = 533) Male vs Female
Median (IQR) Min-Max Median (IQR) Min-Max Median (IQR) Min-Max p-value
Age (years) 39 (18) 20–65 39 (21) 18–64 39 (20) 18–65 0.971
Height (cms) 172 (8) 156–191 160 (9) 143–191 167 (13) 143–191 0.000
Weight (kg) 74 (19) 46–116 68 (16) 38–109 70 (18) 38–116 0.000
BMI (kg/m2) 24.9 (5.6) 16.3–34.9 26.1 (6.3) 17.1–38.1 25.5 (5.9) 16.3–38.1 0.051
BSA (m2) 1.88 (0.24) 1.44–2.36 1.72 (0.20) 1.27–2.24 1.78 (0.22) 1.27–2.36 0.000
Abd. Circ. (cm) 91 (15) 65–124 86 (16) 64–115 89 (17) 64–124 0.005
BP Systolic (mmHg) 127 (18) 84–179 128 (18) 118 (20) 124 (21) 77–194 0.000
BP Diastolic (mmHg) 81 (12) 56–101 79 (14) 57–112 80 (14) 56–112 0.003
aFPG (mmol/L) 4.9 (0.8) 3.0–15.6 4.8 (0.7) 3.3–19.5 4.9 (0.8) 3.0–19.5 0.191
Creatinine (μmol/L) 80 (20) 50–126 61 (15) 30–93 70 (21) 30–126 0.000
4v–MDRD eGFR (mL/min/1.73m2) 114 (34) 61–184 118 (34) 69–251 115 (33) 61–251 0.126
4v–MDRDb eGFR (mL/min/1.73m2) 94 (28) 50–152 97 (28) 57–207 95 (28) 50–207 0.126
CKDEPI eGFR (mL/min/1.73m2) 118 (25) 60–151 124 (25) 71–168 121 (25) 60–168 0.090
CKDEPI eGFRb (mL/min/1.73m2) 102 (21) 52–130 107 (22) 62–146 105 (22) 52–146 0.061
CG eGFRc (mL/min/1.73m2) 103 (26) 55–163 163 (45) 85–345 128 (61) 55–345 0.000
FAS eGFR (mL/min/1.73m2) 100 (23) 51–163 104 (25) 58–200 102 (25) 51–200 0.309
KEY: IQR Interquartile range, Abd.Circ. Abdominal circumference, BMI Body Mass Index, BP Blood pressure, FPG Fasting plasma glucose (a5 males didn’t have this
test done), bNot corrected for race, cCorrected for body surface area
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asymptomatic population not known to have risk factors
for CKD. Unlike the MDRD equation which was derived
from individuals with CKD, CKD-EPI was derived from
a heterogeneous population that included healthy
individuals [9]. Rule et al. used different equations to
screen for CKD in a general population and found that
equations derived from a CKD population gave higher
estimates of CKD prevalence compared to equations
derived from a population that included healthy individuals
[21]. It is therefore not surprising that the CKD-EPI equa-
tion classified less participants as having a reduced eGFR
compared to the 4v–MDRD equation.
There has been a debate as to the suitability of the
60 ml/min/1.73m2 eGFR cut off for defining CKD in
young adults and the elderly. Pottel et al. suggested that a
cut off of 75 ml/min/1.73m2 would be more ideal in young
adults under 40 years of age given that one would require a
serum creatinine almost 1.8 times above the mean value
for this population to achieve an eGFR less than 60 ml/
min/1.73m2 making this cut off quite insensitive to early
increments in serum creatinine [18]. Gharbi et al.
demonstrated that in an Arabic-Berber adult population in
Morocco, using a cut off of 60 ml/min/1.73m2 resulted in
under diagnosis of CKD in younger adults and over diag-
nosis in the elderly population [22]. In our study, based on
a cut off of 75 ml/min/1.73m2, no one under the age of
40 years had reduced eGFR when determined using CG
corrected for BSA, 4v–MDRD or CKD-EPI equations
corrected for race. The FAS equation that can be applied
across a wide age spectrum classified 5 (1.9%) individuals
less than 40 years of age as having a reduced eGFR
compared to 21 (7.8%) for the 4v–MDRD equation without
correction for race. In the absence of mGFR, testing for
albuminuria or demonstrating persistence of reduced
eGFR for at least 3 months, it is difficult to conclude which
individuals truly had CKD and which equation was
correctly classifying them as such.
We determined eGFR correlation with known risk
factors for CKD such as age, BMI, BP, glycaemia and
abdominal circumference. We assumed that in the absence
of mGFR, the multiple correlation coefficient would serve
as indirect proof of appropriateness for routine reporting
of eGFR in an asymptomatic population as it is a measure
of linear association between the predicted eGFR after
factoring in the CKD risk factors and eGFR determined
using the various equations. The CKD-EPI and CG
corrected for BSA equations had the highest multiple cor-
relation coefficients suggesting that the the model best fit-
ted these equations. However, given that age is one of the
components of the CG equation and both height and
weight are used in the calculation of BMI and BSA, there
is a possibility that the CG multiple correlation coefficient
after correction for BSA is inaccurate due to possible col-
linearity. Age remained the only risk factor that showed a
Table 2 CKD classification and correlation of eGFR with risk factors
CGb 4v–MDRD 4v–MDRDa CKD-EPI CKD-EPIa FAS
CKD classification based on eGFR
No. (%)
G1 478 (89.7%) 473 (88.7%) 329 (61.7%) 499 (93.6%) 433 (81.2%) 402 (75.4%)
G2 54 (10.1%) 60 (11.3%) 199 (37.3%) 34 (6.4%) 99 (18.6%) 129 (24.2%)
G3a 1 (0.2%) 0 (0.0%) 5 (0.9%) 0 (0.0%) 1 (0.2%) 2 (0.4%)
No. (%) below 40 years with eGFR
< 75 ml/min/1.73m2 (n = 270)
0 (0.0%) 0 (0.0%) 21 (7.8%) 0 (0.0%) 1 (0.4%) 5 (1.9%)
eGFR (ml/min/1.73m2) mean (SD)
18–29 years (n = 135) 149.0 (40.9) 129.5 (21.8) 106.8 (18.0) 135.3 (15.6) 117.2 (13.5) 108.9 (15.5)
30–39 years (n = 135) 136.7 (39.2) 112.1 (20.2) 92.6 (16.7) 119.1 (15.8) 103.2 (13.7) 102.9 (15.8)
40–49 years (n = 132) 139.8 (43.6) 117.0 (25.4) 96.6 (20.9) 117.6 (14.8) 101.8 (12.8) 106.7 (19.8)
50–65 years (n = 131) 120.8 (35.1) 111.9 (25.0) 92.3 (20.6) 107.6 (15.2) 93.2 (13.1) 92.2 (18.4)
Multiple correlation coefficient (R) 0.563 0.305 0.306 0.568 0.568 0.350
Unstandardized (B) coefficients (standard error)
Age −0.621* (0.151) −0.322* (0.102) −0.267* (0.084) −0.673* (0.067) −0.579* (0.058) −0.403* (0.077)
BMI 7.418* (0.567) −0.596 (0.382) −0.491 (0.315) −0.188 (0.252) −0.129 (0.218) −0.405 (0.289)
Systolic BP −0.485* (0.140) −0.121 (0.094) −0.099 (0.078) −0.116 (0.062) −0.102 (0.054) −0.119 (0.071)
Diastolic BP 0.237 (0.202) 0.139 (0.136) 0.115 (0.112) 0.142 (0.090) 0.124 (0.078) 0.117 (0.103)
Abd.Circ. −2.049* (0.231) −0.178 (0.156) −0.148 (0.128) −0.184 (0.103) −0.172 (0.089) −0.028 (0.118)
FPG 0.579 (1.170) 1.106 (0.788) 0.912 (0.650) 0.610 (0.519) 0.500 (0.450) 0.807 (0.596)
KEY: Abd.Circ. Abdominal circumference, BP Blood pressure, BMI Body Mass Index, CKD Chronic kidney disease, FPG Fasting plasma glucose, aNot corrected for
race, bCorrected for body surface area, * Significant at a p-value <0.05
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statistically significant linear association with eGFR across
all eGFR equations. Matsha et al. demonstrated that age,
gender and known history of hypertension were determi-
nants of CKD stage 3–5 in a mixed ancestry population in
South Africa. Surprisingly, this was not the case for FPG,
BMI, systolic and diastolic BP. However, this study did not
correlate eGFR with these potential risk factors but rather
used logistic regression to determine the odds of having a
reduced eGFR [23]. Kaze et al. concluded that in a rural
and urban population in Cameroon, elevated systolic BP,
presence of hypertension and diabetes were the main pre-
dictors of albuminuria and CKD [20]. In the Democratic
Republic of Congo, a study by Sumaili et al. found that age
above 65 years and hypertension were independently
associated with increased risk of CKD stage 3–5 [24].
The issue of whether or not one should correct for the
black African race when using eGFR equations has not
been settled. Deventer et al. concluded that correction for
the African race was not necessary when using the 4v–
MDRD equation after they compared eGFR with mGFR
in 100 black African patients with CKD and found a
greater bias after correcting for race [5]. The mean weight
of the participants in this study was 69.5 kg with a BSA of
1.76 m2 compared to a weight of 79.6 kg and BSA of
1.91 m2 for the MDRD population which included only
197 (12.1%) African Americans [25]. The adjustment for
the African race is extrapolated from the African-
American MDRD study population who had a higher
mean weight and BSA compared to the Caucasian popula-
tion necessitating a correction of the original 4v–MDRD
eGFR equation by a factor of 1.18 that was further
adjusted to 1.212 after standardization of the creatinine
assay. Since serum creatinine levels are affected by muscle
mass, it is not surprising that the 4v–MDRD equation
without correction for race better approximated mGFR in
the South African population given a closer similarity in
weight and by extension muscle mass of their study popu-
lation to the Caucasian population used in deriving the
equation. A study carried out in Ghana in a rural popula-
tion of black Africans also concluded that correction for
race was unnecessary for both the 4v–MDRD and CKD-
EPI equations. This study compared eGFR to CrCl and
the mean weight of the participants was 54.4 kg [6]. Fla-
mant et al. compared CKD-EPI and 4v–MDRD derived
eGFR to mGFR in African Europeans originating from
West Africa and concluded that a correction factor of 1.08
was required. However, most of the patients in this study
had CKD with a mean mGFR of 57.6 ml/min/1.73m2 [26].
Delanaye et al. has argued that the correction factor for
race when using the 4v–MDRD or CKD-EPI equations
should vary depending on whether it is being applied in
individuals with CKD and an eGFR < 60 ml/min/1.73m2
or healthy subjects due to the inherent difference in how
these 2 populations handle serum creatinine even within
the same race [27]. In our study we didn’t compare eGFR
to either mGFR or CrCl but rather compared the propor-
tion of healthy black Africans classified as having a re-
duced or normal eGFR across the different equations and
eGFR correlation with a prediction model comprising risk
factors for CKD. Since the correction factor for race for
both 4v–MDRD and CKD-EPI is greater than one, it is
not surprising that correction for race resulted in higher
eGFRs. However, the CKD EPI equation had a higher me-
dian eGFR and proportion of individuals with eGFR >
90 ml/min/1.73m2 compared to 4v–MDRD or FAS as well
as better correlation with risk factors for CKD. This is not
surprising as CKD-EPI is more accurate than the 4v–
MDRD equation in individuals with a GFR >60 ml/min/
1.73m2 and would be expected to be more appropriate for
the subjectively healthy population recruited in this study
[9]. The presence of a larger proportion of healthy individ-
uals in the CKD-EPI dataset makes it more suitable for
reporting eGFR in healthy subjects [21]. The FAS equation
was developed to overcome the potential differences in
eGFR associated with adoption of different equations. The
equation incorporates population normalized serum cre-
atinine levels and therefore gets rid of the need for further
age, gender and race correction. This equation has been
shown to be less biased than the CKD-EPI equation when
applied on data sets largely comprised of a Caucasian
population and therefore requires validation in an ethnic
black African population [11]. In our study, the FAS deter-
mined eGFR had similar correlation coefficients with
CKD risk factors as the 4v–MDRD equation and demon-
strated a similar pattern in change of mean eGFR with age
where the mean eGFR in the age group 40–49 years was
higher than in the age group 30–39 years. Of the 6 equa-
tions, only the CKD-EPI derived mean eGFRs showed a
consistent decline with increase in age across the 4 age
stratifications in line with the expected reduction of eGFR
associated with progressive loss of nephrons above the age
of 30 years [28].
The median eGFR for female participants calculated
using the various equations was consistently higher than
male participants in our study though this difference was
not statistically significant except for eGFR determined
using CG corrected for BSA. This is in contrast to the
Ghanaian study by Eastwood et al. where the female
participants had a lower mean eGFR when determined
using both the 4v–MDRD and CKD-EPI equations with
and without correcting for race but not when CG cor-
rected for BSA was used. Similar to our study, the Ghan-
aian women had a higher BMI but lower weight and blood
pressure compared to the men [6]. No obvious explanation
is forthcoming for the relatively better eGFR seen in
women compared to men in our study. The Ghanaian
rural population had a higher percentage (13.2%) of indi-
viduals with reduced eGFR (< 60 ml/min/1.73m2)
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compared to < 1% in our study population which can
partially be explained by the fact that we recruited a
younger population ranging from 18 to 65 years compared
to 40–75 years for the Ghanaian population with 50.8% of
our study population being under the age of 40 years. We
also had a strict inclusion and exclusion criteria to ensure
that as far as possible only healthy individuals were
recruited.
A major limitation of our study is that we didn’t measure
GFR and as such our comparison of various eGFR
equations is not validated against a gold standard. In the
absence of mGFR, we chose to use correlation with a
prediction model of markers known to increase risk of
CKD but are not included in the eGFR equations as a basis
of comparison. Our assumption was that equations whose
eGFR calculations best correlated with these risk factors
were potentially better equations to be used when
screening for CKD in an asymptomatic black African
population. This is not equivalent to mGFR and therefore
limits the extent to which conclusions can be made as to
which equation is better. Another major limitation is that
we didn’t carry out any test for albuminuria neither did we
repeat serum creatinine measurements after 3 months
hence we cannot accurately comment on the prevalence of
CKD in this population. Gharbi et al. found that 32% of
the subjects classified as having CKD stage 3a and 7.4% of
those classified as 3b had an eGFR > 60 ml/min/1.73 m2
when reinvestigated after 3 months or longer [22].
However, the proportion of participants with an eGFR
<60 ml/min/1.73 m2 in our study was less than 1% hence
the risk of over diagnosing CKD in this healthy population
was extremely low. What is more likely is that we may
have under diagnosed CKD due to failure to test for
albuminuria. We also assumed that diabetes and
hypertension are the commonest risk factors for CKD in
our population which may not necessarily be the case as
demonstrated by Stanifer et al. in Northern Tanzania
where 49.1% of individuals with CKD didn’t have
hypertension, diabetes or HIV [29]. We also didn’t
measure cystatin C which has been shown by Meeusen et
al. to significantly improve eGFR estimation across
different patient groups including healthy kidney donors
when incorporated into the CKD-EPI equation [30].
Conclusion
The CKD-EPI equation with correction for race classi-
fied the highest proportion of asymptomatic healthy
black Africans as having an eGFR >90 ml/min/1.73m2
and its eGFR better correlated with risk factors for CKD.
For this reason, we recommend the use of the CKD-EPI
equation with correction for race for routine reporting
of eGFR in an asymptomatic black African population
with a low prevalence of risk factors for CKD. Compar-
ing eGFR to mGFR would be the best way to determine
the most appropriate equation for CKD screening in an
asymptomatic black African population. However, meas-
urement of GFR is a complex and expensive process
which serves as a barrier for the validation of eGFR
equations especially in sub Saharan Africa. In the ab-
sence of mGFR, other ways of evaluating the potential
utility and performance of eGFR equations in routine
screening for CKD in asymptomatic populations need to
be evaluated.
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